This is the classic website, which will be retired eventually. Please visit the modernized ClinicalTrials.gov instead.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Evaluating a New Mental Health Group for Asians and Asian Americans

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT06185959
Recruitment Status : Not yet recruiting
First Posted : December 29, 2023
Last Update Posted : April 17, 2024
Sponsor:
Information provided by (Responsible Party):
Lisa Zhang, Stanford University

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
This study's overarching aim is to evaluate a new psychoeducation and process group for Asian and Asian American psychiatric outpatients. This is a 12 week mental health group which will focus on both educational content related to Asian mental health as well as increasing connection between group members. We hypothesize that participants in the group will experience a decrease in psychiatric symptoms at the conclusion of the group compared to their symptoms at the beginning of group. We also hypothesize that participants will feel more socially connected after the group.

Condition or disease Intervention/treatment
Mental Health Issue Behavioral: Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Estimated Enrollment : 30 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Examining the Feasibility and Impact of a Novel Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients
Estimated Study Start Date : June 1, 2024
Estimated Primary Completion Date : June 1, 2027
Estimated Study Completion Date : June 1, 2027

Resource links provided by the National Library of Medicine


Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Group/Cohort Intervention/treatment
Patients in a Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients Behavioral: Psychoeducation and Process Group for Asian and Asian American Psychiatric Outpatients
Participants will be individuals enrolling in a 1.5 hour weekly therapy group lasting 12 weeks and will be invited to participate in research on group processes and outcomes. The psychoeducation and process group will be a 12-session weekly closed group with 10-15 participants per group (2-3 groups total) conducted via Zoom to enhance accessibility and reduce barriers to care. Groups will be co-led by licensed clinical psychologists with experience providing both group psychotherapy and culturally responsive services. Group sessions will include brief check-ins, collaborative agenda-setting, a mini-didactic, individual reflection, and group discussion. The didactics curriculum will include topics such as intergenerational trauma, cultural differences in emotional expression, the model minority myth, family dynamics, racism, and positive connections to culture.


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Patient Health Questionnaire-9 (PHQ-9) [ Time Frame: Once at baseline, once at 6 weeks, once at 12 weeks ]
    Depression symptoms assessed on 4-point Likert scale. Score range from 0 to 27, with higher scores representing more severe depression symptoms

  2. Generalized Anxiety Disorder Screener-7 (GAD-7) [ Time Frame: Once at baseline, once at 6 weeks, once at 12 weeks ]
    Anxiety symptoms assessed on 4-point Likert scale. Score range from 0 to 21, with higher scores representing more severe anxiety symptoms


Secondary Outcome Measures :
  1. Social Connectedness Scale [ Time Frame: Once at baseline, once at 12 weeks ]
    Subjective social connectedness assessed on 6-point Likert scale. Score range from 20 to 120, with higher scores representing higher perceived social connectedness

  2. Rosenberg Self-Esteem Scale [ Time Frame: Once at baseline, once at 12 weeks ]
    Subjective self-esteem assessed on 4-point Likert scale. Score range from 10 to 40, with higher scores representing higher self-esteem

  3. Self-Stigma of Seeking Help Scale [ Time Frame: Once at baseline, once at 12 weeks ]
    Help-seeking self-stigma assessed on 5-point Likert scale. Score range from 10 to 50, with higher scores representing higher self-stigma of seeking help


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years and older   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population

Age range is 18 years and older. All genders are eligible. For ethnic background, to be eligible for this study, participants must identify as Asian or Asian American due to the group under investigation being specifically designed as an Asian and Asian American Psychoeducation and Process Group.

The research study will be offered to all patients enrolling in the Asian and Asian American Psychoeducation and Process Group in the Stanford Department of Psychiatry & Behavioral Sciences. The purpose of this study is to evaluate patient experiences in this psychoeducation and process group, so participants will be limited to those enrolling in the group as part of their clinical treatment.

Criteria

Inclusion Criteria:

  • 18 years and older
  • Participants must identify as Asian or Asian American
  • Sufficient English proficiency to participate in a psychotherapy group conducted in English

Exclusion Criteria:

  • Unable to provide written informed consent
  • Elevated suicide risk (e.g. recent active suicidal ideation, past-year suicide attempt) without a current individual mental health provider
  • Any other challenges that would preclude participation in group psychotherapy
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT06185959


Contacts
Layout table for location contacts
Contact: Lisa Zhang, PhD 650-721-8590 lisaz@stanford.edu

Sponsors and Collaborators
Stanford University
Investigators
Layout table for investigator information
Principal Investigator: Lisa Zhang, PhD Stanford University
Principal Investigator: Melanie Hom, PhD Stanford University
Principal Investigator: Stacy Lin, PhD Stanford University
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Layout table for additonal information
Responsible Party: Lisa Zhang, Clinical Assistant Professor, Stanford University
ClinicalTrials.gov Identifier: NCT06185959    
Other Study ID Numbers: 72936
First Posted: December 29, 2023    Key Record Dates
Last Update Posted: April 17, 2024
Last Verified: April 2024
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No